Intradermally injected abobotulinumtoxinA, administered in intact animals preemptively, before surgery, alleviates post-surgical pain, reduces distress and normalizes behavior in a translational animal model
Preprint in Research Square (June 2024)
The most recent citing publications are shown below. View all 33 publications that cite this research output on Dimensions.
Botulinum toxin type A is a potential therapeutic drug for chronic orofacial pain
Article in Journal of Oral Biosciences (June 2024)
Neurobiological mechanisms of botulinum neurotoxin-induced analgesia for neuropathic pain
Article in Pharmacology & Therapeutics (May 2024)